NASDAQ
aTyr Pharma, Inc. (ATYR) has a free cash flow growth of -3.50% as of Friday, May 29, 2026. This represents a 3.52% increase compared to its 12-month average of -3.63%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.